Literature DB >> 22356115

Association of adiponectin with blood pressure in healthy people.

Megu Y Baden1, Yuya Yamada, Yasumitsu Takahi, Yoshinari Obata, Kenji Saisho, Sachiko Tamba, Koji Yamamoto, Miyuki Umeda, Aiko Furubayashi, Yoshifumi Tsukamoto, Katsuhiko Sakaguchi, Yuji Matsuzawa.   

Abstract

OBJECTIVE: With the increasing prevalence of diseases related to obesity, metabolic syndrome and its key player adiponectin are now attracting considerable attention. Hypoadiponectinaemia is reported to be a risk factor for hypertension and associated with endothelial dysfunction, which is closely related to complications of obesity such as hypertension. As there is limited information regarding serum adiponectin levels in normotensive people, we undertook the large-scale study to determine the association of adiponectin with blood pressure (BP) in mainly normotensive people. DESIGN, PATIENTS AND MEASUREMENTS: In 21 100 Japanese adults (12 363 men and 8737 women) who had no apparent diseases, we examined the relationship between the serum adiponectin concentration and BP by performing a questionnaire survey, physical measurements and measurement of laboratory parameters including the serum adiponectin level.
RESULTS: Subjects with hypoadiponectinaemia had higher systolic and diastolic BPs as already reported. And interestingly, subjects with higher adiponectin had lower systolic and diastolic BP. According to linear regression analysis, adiponectin showed a significant negative correlation with systolic and diastolic BP independently of the other variables. Analysis of covariance according to adiponectin quintiles showed that systolic and diastolic BP in highest adiponectin quintile was significantly lower than in other quintiles.
CONCLUSIONS: This study revealed that there were significant trends toward lower systolic and diastolic BP with higher adiponectin not only in hypertensive people but also in normotensive people.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22356115     DOI: 10.1111/j.1365-2265.2012.04370.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  15 in total

1.  Adiponectin resistance parameter as a marker for high normal blood pres-sure and hypertension in patients with metabolic syndrome.

Authors:  S Stojanovic; M Deljanin-Ilic; S Ilic; M Stefanovic; D Petrovic; V Petrovic; M Stojanovic
Journal:  Hippokratia       Date:  2020 Jan-Mar       Impact factor: 0.471

Review 2.  The role of adiponectin in endothelial dysfunction and hypertension.

Authors:  Edward Rojas; Daloha Rodríguez-Molina; Peter Bolli; Zafar H Israili; Judith Faría; Enzamaría Fidilio; Valmore Bermúdez; Manuel Velasco
Journal:  Curr Hypertens Rep       Date:  2014-08       Impact factor: 5.369

Review 3.  Differential Role of Leptin and Adiponectin in Cardiovascular System.

Authors:  C M Ghantous; Z Azrak; S Hanache; W Abou-Kheir; A Zeidan
Journal:  Int J Endocrinol       Date:  2015-05-03       Impact factor: 3.257

4.  Relationship between Adiponectin Level, Insulin Sensitivity, and Metabolic Syndrome in Type 1 Diabetic Patients.

Authors:  Kristina Blaslov; Tomislav Bulum; Karin Zibar; Lea Duvnjak
Journal:  Int J Endocrinol       Date:  2013-07-17       Impact factor: 3.257

5.  Association of adiponectin and metabolic syndrome in adolescents: the caspian- III study.

Authors:  Gita Shafiee; Zeinab Ahadi; Mostafa Qorbani; Roya Kelishadi; Hassan Ziauddin; Bagher Larijani; Ramin Heshmat
Journal:  J Diabetes Metab Disord       Date:  2015-12-18

6.  Key Clinical Factors Predicting Adipokine and Oxidative Stress Marker Concentrations among Normal, Overweight and Obese Pregnant Women Using Artificial Neural Networks.

Authors:  Mario Solis-Paredes; Guadalupe Estrada-Gutierrez; Otilia Perichart-Perera; Araceli Montoya-Estrada; Mario Guzmán-Huerta; Héctor Borboa-Olivares; Eyerahi Bravo-Flores; Arturo Cardona-Pérez; Veronica Zaga-Clavellina; Ethel Garcia-Latorre; Gabriela Gonzalez-Perez; José Alfredo Hernández-Pérez; Claudine Irles
Journal:  Int J Mol Sci       Date:  2017-12-28       Impact factor: 5.923

7.  The Effect of Renal Denervation on Plasma Adipokine Profile in Patients with Treatment Resistant Hypertension.

Authors:  Nina Eikelis; Dagmara Hering; Petra Marusic; Jacqueline Duval; Louise J Hammond; Antony S Walton; Elisabeth A Lambert; Murray D Esler; Gavin W Lambert; Markus P Schlaich
Journal:  Front Physiol       Date:  2017-05-30       Impact factor: 4.566

8.  Association of adipokines with blood pressure, arterial elasticity and cardiac markers in dialysis patients: cross-sectional analysis of baseline data from a cohort study.

Authors:  Wenjin Liu; Lei Jiang; Jianping Chen; Chaoqing Gao; Jianmei Zhou; Jiajun Zhou; Youwei Bai; Hong Chu; Wei Fan; Liang Wang; Zhuxing Sun; Xiurong Li; Junwei Yang
Journal:  Nutr Metab (Lond)       Date:  2017-05-10       Impact factor: 4.169

9.  Increased circulating ANG II and TNF-α represents important risk factors in obese saudi adults with hypertension irrespective of diabetic status and BMI.

Authors:  Nasser M Al-Daghri; Lotfi S Bindahman; Omar S Al-Attas; Tahia H Saleem; Majed S Alokail; Khalid M Alkharfy; Hossam M Draz; Sobhy Yakout; Amany O Mohamed; Alison L Harte; Philip G McTernan
Journal:  PLoS One       Date:  2012-12-12       Impact factor: 3.240

10.  Obesity, high-molecular-weight (HMW) adiponectin, and metabolic risk factors: prevalence and gender-specific associations in Estonia.

Authors:  Triin Eglit; Inge Ringmets; Margus Lember
Journal:  PLoS One       Date:  2013-09-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.